Sqi Diagnostics Inc (SQIDF) 0.1680 $SQIDF SQI S
Post# of 273242
Posted On: 09/19/2016 9:04:07 PM
Sqi Diagnostics Inc (SQIDF) 0.1680 $SQIDF
SQI Sells Second sqidlite™-DH System to Diagnostics Segment Customer
PR Newswire - Mon Sep 12, 8:00AM CDT
Major Milestone in Commercialization
SQD.VN: 0.225 (-0.005)
SQI Sells Second sqidlite(TM)-DH System to Diagnostics Segment Customer
CNW Group - Mon Sep 12, 8:00AM CDT
Major Milestone in Commercialization
SQD.VN: 0.225 (-0.005)
SQI Sells Sqidlite System to Global Pharmaceutical Customer
PR Newswire - Tue Aug 30, 8:00AM CDT
SQI Diagnostics Inc. (TSX-V: SQD; OTCQX: SQIDF) (the "Company" or "SQI"
, today announced the sale of a sqidlite(TM) system under the terms of an agreement with a top tier global pharmaceutical customer.
SQD.VN: 0.225 (-0.005)
SQI Diagnostics Reports Third Quarter 2016 Results
PR Newswire - Thu Aug 18, 7:30AM CDT
SQI Diagnostics Inc. ("SQI" or the "Company" (TSX-V: SQD; OTCQX: SQIDF), today reported its financial and operational results for the three and nine months ended June 30, 2016.
SQD.VN: 0.225 (-0.005)
SQI Diagnostics to Announce Third Quarter 2016 Results
CNW Group - Tue Aug 02, 8:29AM CDT
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company" (TSX-V: SQD) (OTCQX: SQIDF), today announced that it plans to release its financial and operational results for the three and nine months ended June 30, 2016 at 8:30am EST Thursday, August 18, 2016. President and CEO, Andrew Morris, along with Company management, will host a conference call on Thursday, August 18, 2016 at 10:00 a.m. ET to review financial results and discuss business developments for the period.
SQD.VN: 0.225 (-0.005)
SQI Diagnostics Reports Second Quarter 2016 Results
CNW Group - Fri May 13, 7:30AM CDT
SQI Diagnostics Inc. ("SQI" or the "Company" (TSX-V: SQD; OTCQX: SQIDF), today reported its financial and operational results for the three and six months ended March 31, 2016.
SQD.VN: 0.225 (-0.005)
SQI Diagnostics to Announce Second Quarter 2016 Results
PR Newswire - Fri Apr 29, 7:48AM CDT
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company" (TSX-V: SQD; OTCQX: SQIDF), today announced that it plans to release its financial and operational results for the three and six months ended March 31, 2016 at 8:30am EST Friday, May 13, 2016. President and CEO, Andrew Morris, along with Company management, will host a conference call on Friday, May 13, 2016 at 10:00 a.m. ET to review financial results and discuss business developments for the period.
SQD.VN: 0.225 (-0.005)
Allergan to Highlight SQI Diagnostics' Technology at 10th WRIB Conference
PR Newswire - Mon Apr 18, 9:56AM CDT
SQI Diagnostics Inc. . ("SQI Diagnostics" "SQI" or the "Company" (TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics today announced that its immunogenicity testing technology is being presented by Allergan at the 10th Workshop on Recent Issues in Bioanalysis in Orlando, Florida ("10th WRIB", on April 19, 2016.
AGN: 245.29 (+0.10), SQD.VN: 0.225 (-0.005)
SQI Diagnostics to Announce First Quarter 2016 Results
PR Newswire - Thu Feb 04, 8:00AM CST
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company" (TSX-V: SQD; OTCQX: SQIDF), today announced that it plans to release its financial and operational results for the three months ended December 31, 2015 at 8:30am ET Thursday, February 11, 2016. President and CEO, Andrew Morris, along with Company management, will host a conference call on Thursday February 11, 2016 at 10:00 a.m. ET to review financial results and discuss business developments for the period.
SQD.VN: 0.225 (-0.005)
SQI Diagnostics to Extend Warrant Expiry
PR Newswire - Thu Jan 14, 3:15PM CST
SQI Diagnostics Inc. (TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics ("SQI", today announced that it intends to extend the expiry of 2,965,000 outstanding common share purchase warrants ("the Warrants" of the Company, which were issued in connection with the Company's January 2014 private placement financing. The extension is subject to approval from the TSX Venture Exchange.
SQD.VN: 0.225 (-0.005)
SQI Diagnostics Reports Fourth Quarter and Fiscal 2015 Results
PR Newswire - Wed Dec 16, 4:00PM CST
Multiple Customer Agreements Position SQI for Realization of Commercial Revenues in 2016
SQD.VN: 0.225 (-0.005)
SQI Sells Second sqidlite™-DH System to Diagnostics Segment Customer
PR Newswire - Mon Sep 12, 8:00AM CDT
Major Milestone in Commercialization
SQD.VN: 0.225 (-0.005)
SQI Sells Second sqidlite(TM)-DH System to Diagnostics Segment Customer
CNW Group - Mon Sep 12, 8:00AM CDT
Major Milestone in Commercialization
SQD.VN: 0.225 (-0.005)
SQI Sells Sqidlite System to Global Pharmaceutical Customer
PR Newswire - Tue Aug 30, 8:00AM CDT
SQI Diagnostics Inc. (TSX-V: SQD; OTCQX: SQIDF) (the "Company" or "SQI"
, today announced the sale of a sqidlite(TM) system under the terms of an agreement with a top tier global pharmaceutical customer. SQD.VN: 0.225 (-0.005)
SQI Diagnostics Reports Third Quarter 2016 Results
PR Newswire - Thu Aug 18, 7:30AM CDT
SQI Diagnostics Inc. ("SQI" or the "Company"
(TSX-V: SQD; OTCQX: SQIDF), today reported its financial and operational results for the three and nine months ended June 30, 2016. SQD.VN: 0.225 (-0.005)
SQI Diagnostics to Announce Third Quarter 2016 Results
CNW Group - Tue Aug 02, 8:29AM CDT
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company"
(TSX-V: SQD) (OTCQX: SQIDF), today announced that it plans to release its financial and operational results for the three and nine months ended June 30, 2016 at 8:30am EST Thursday, August 18, 2016. President and CEO, Andrew Morris, along with Company management, will host a conference call on Thursday, August 18, 2016 at 10:00 a.m. ET to review financial results and discuss business developments for the period. SQD.VN: 0.225 (-0.005)
SQI Diagnostics Reports Second Quarter 2016 Results
CNW Group - Fri May 13, 7:30AM CDT
SQI Diagnostics Inc. ("SQI" or the "Company"
(TSX-V: SQD; OTCQX: SQIDF), today reported its financial and operational results for the three and six months ended March 31, 2016. SQD.VN: 0.225 (-0.005)
SQI Diagnostics to Announce Second Quarter 2016 Results
PR Newswire - Fri Apr 29, 7:48AM CDT
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company"
(TSX-V: SQD; OTCQX: SQIDF), today announced that it plans to release its financial and operational results for the three and six months ended March 31, 2016 at 8:30am EST Friday, May 13, 2016. President and CEO, Andrew Morris, along with Company management, will host a conference call on Friday, May 13, 2016 at 10:00 a.m. ET to review financial results and discuss business developments for the period. SQD.VN: 0.225 (-0.005)
Allergan to Highlight SQI Diagnostics' Technology at 10th WRIB Conference
PR Newswire - Mon Apr 18, 9:56AM CDT
SQI Diagnostics Inc. . ("SQI Diagnostics" "SQI" or the "Company"
(TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics today announced that its immunogenicity testing technology is being presented by Allergan at the 10th Workshop on Recent Issues in Bioanalysis in Orlando, Florida ("10th WRIB", on April 19, 2016. AGN: 245.29 (+0.10), SQD.VN: 0.225 (-0.005)
SQI Diagnostics to Announce First Quarter 2016 Results
PR Newswire - Thu Feb 04, 8:00AM CST
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company"
(TSX-V: SQD; OTCQX: SQIDF), today announced that it plans to release its financial and operational results for the three months ended December 31, 2015 at 8:30am ET Thursday, February 11, 2016. President and CEO, Andrew Morris, along with Company management, will host a conference call on Thursday February 11, 2016 at 10:00 a.m. ET to review financial results and discuss business developments for the period. SQD.VN: 0.225 (-0.005)
SQI Diagnostics to Extend Warrant Expiry
PR Newswire - Thu Jan 14, 3:15PM CST
SQI Diagnostics Inc. (TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics ("SQI"
, today announced that it intends to extend the expiry of 2,965,000 outstanding common share purchase warrants ("the Warrants" of the Company, which were issued in connection with the Company's January 2014 private placement financing. The extension is subject to approval from the TSX Venture Exchange. SQD.VN: 0.225 (-0.005)
SQI Diagnostics Reports Fourth Quarter and Fiscal 2015 Results
PR Newswire - Wed Dec 16, 4:00PM CST
Multiple Customer Agreements Position SQI for Realization of Commercial Revenues in 2016
SQD.VN: 0.225 (-0.005)
(0)
(0)Scroll down for more posts ▼